SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Investing in Exponential Growth

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Paul H. Christiansen5/10/2020 11:26:47 AM
  Read Replies (1) of 965
 
The PlarityTE (PTE) Enigma

The Diabetic Foot Ulcer (DFU) Total Addressable Market (TAM) is projected to be $11 billion/year by 2026.

The Venus Leg Ulcer (VLU) TAM is projected to be $5 billion by 2026.

The burn TAM is projected to be $3 billion by 2026.

The TAM for these three treatments $19 billionper year.

Given the possibility that PTE’s SkinTE could become the Standard of Care for all three of these markets, let’s assume that PTE could achieve 15% annually of those markets.

That projects to $2.85 billion annual revenues.

PTE currently has a market cap of $34.9 million, with roughly 38.4 millions shares issued and outstanding.

If a larger pharmaceutical company was willing to buy PTE at a price equal to the projected revenues in 2026 ($2.85 billion) the acquisition cost would be roughly $74 per share.

The stock closed on Friday, May 8, 2020 at $0.91 per share.



Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext